Literature DB >> 10051154

Effects of pyrogallol, hydroquinone and duroquinone on responses to nitrergic nerve stimulation and NO in the rat anococcygeus muscle.

M La1, M J Rand.   

Abstract

1. The hypothesis that endogenous superoxide dismutase (SOD) protects the nitrergic transmitter from inactivation by superoxide and that this explains the lack of sensitivity of the transmitter to superoxide generators was tested in the rat isolated anococcygeus muscle. 2. Responses to nitrergic nerve stimulation or to NO were not significantly affected by exogenous SOD or by the Cu/Zn SOD inhibitor diethyldithiocarbamic acid (DETCA). 3. Hydroquinone produced a concentration-dependent reduction of responses to NO with an IC50 of 27 microM, and higher concentrations reduced relaxant responses to nitrergic nerve stimulation with an IC50 of 612 microM. The effects of hydroquinone were only slightly reversed by SOD, so it does not appear to be acting as a superoxide generator. 4. Pyrogallol produced a concentration-dependent reduction in responses to NO with an IC50 value of 39 microM and this effect was reversed by SOD (100-1000 u ml(-1)). Pyrogallol did not affect responses to nitrergic nerve stimulation. Treatment with DETCA did not alter the differentiating action of pyrogallol. 5. Duroquinone produced a concentration-dependent reduction of relaxations to NO with an IC50 value of 240 microM and 100 microM slightly decreased nitrergic relaxations. After treatment with DETCA, duroquinone produced greater reductions of relaxant responses to NO and to nitrergic stimulation, the IC50 values being 8.5 microM for NO and 40 microM for nitrergic nerve stimulation: these reductions were reversed by SOD. 6. The findings do not support the hypothesis that the presence of Cu/Zn SOD explains the greater susceptibility of NO than the nitrergic transmitter to the superoxide generator pyrogallol, but suggest that it may play a role in the effects of duroquinone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051154      PMCID: PMC1565785          DOI: 10.1038/sj.bjp.0702277

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission.

Authors:  M J Rand; C G Li
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

2.  Effect of thiol modulators and Cu/Zn superoxide dismutase inhibition on nitrergic relaxations in the rat gastric fundus.

Authors:  J G De Man; B Y De Winter; G E Boeckxstaens; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Antioxidant protection of NO-induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroquinone and carboxy-PTIO.

Authors:  E Lilley; A Gibson
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Protection of nitrergic neurotransmission by and colocalization of neural nitric oxide synthase with copper zinc superoxide dismutase.

Authors:  X Liu; S M Miller; J H Szurszewski
Journal:  J Auton Nerv Syst       Date:  1997-02-17

5.  Inhibition of relaxations to nitrergic stimulation of the mouse anococcygeus by duroquinone.

Authors:  E Lilley; A Gibson
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Influence of superoxide dismutase inhibition on the discrimination between NO and the nitrergic neurotransmitter in the rat gastric fundus.

Authors:  R A Lefebvre
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Release of the antioxidants ascorbate and urate from a nitrergically-innervated smooth muscle.

Authors:  E Lilley; A Gibson
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

Review 8.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

Authors:  J S Beckman; W H Koppenol
Journal:  Am J Physiol       Date:  1996-11

9.  Manganese superoxide dismutase and reduced nicotinamide adenine dinucleotide diaphorase colocalize in the rat gut.

Authors:  S Fang; J Christensen
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

10.  Inhibition of NO-medicate responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450.

Authors:  C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  7 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus.

Authors:  J G De Man ; T G Moreels; B Y De Winter ; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Interaction of hypoxanthine/xanthine oxidase with nitrergic relaxation in the porcine gastric fundus.

Authors:  E E Colpaert; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Influence of antioxidant depletion on nitrergic relaxation in the pig gastric fundus.

Authors:  E E Colpaert; J-P Timmermans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus.

Authors:  E E Colpaert; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

6.  Effects of superoxide anion generators and thiol modulators on nitrergic transmission and relaxation to exogenous nitric oxide in the sheep urethra.

Authors:  A Garcia-Pascual; A Labadia; G Costa; D Triguero
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

7.  Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt.

Authors:  A Ellis; H Lu; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.